We are live on ! Find out more
VTAK icon

Catheter Precision

9 hedge funds and large institutions have $1.82M invested in Catheter Precision in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more funds holding

Funds holding: 59 (+4)

0% less ownership

Funds ownership: 0%0% (-0%)

17% less capital invested

Capital invested by funds: $2.18M → $1.82M (-$362K)

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q2 2020 in Review

9 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2020, worth a combined $1.82M — down 17% from $2.18M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new VTAK positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $770K. The largest seller was Putnam Investments, cutting an estimated $38K.

  • 9 institutional investors held Catheter Precision (VTAK) as of Q2 2020, up from 5 in Q1 2020.
  • Funds reported $1.82M of Catheter Precision stock for Q2 2020, down 17% quarter-over-quarter.
  • 4 funds opened new Catheter Precision positions in Q2 2020 and 0 closed out, a net change of +4 holders.
  • The largest Catheter Precision buyer in Q2 2020 was Renaissance Technologies, an estimated $770K added.
  • The largest Catheter Precision seller in Q2 2020 was Putnam Investments, an estimated $38K sold.

Based on aggregated 13F filings for Q2 2020.